Globalization makes this more likely. Before globalization there were manufacturers distributed all over serving different markets. Now there are global monopolies on production (for particular drugs), which makes production very vulnerable to supply chain disruption.

AFAIK that's what the pharmacist hinted at, there are brands, but the manufacturing plants are shared.